Bioquímica quântica de interações ligante-proteína entre entre potenciais agentes anti maláricos e as enzimas DHODH e TyrRS do Plasmodium falciparum
Malaria is a parasitic disease caused by unicellular protozoa of the genus Plasmodium and occurs in more than 90 countries, with the African and Asian continents predominating. The use of antimalarial drugs is critical for both treatment and prevention of the disease. However, the parasites began...
Na minha lista:
Autor principal: | |
---|---|
Outros Autores: | |
Formato: | doctoralThesis |
Idioma: | pt_BR |
Publicado em: |
Universidade Federal do Rio Grande do Norte
|
Assuntos: | |
Endereço do item: | https://repositorio.ufrn.br/handle/123456789/57421 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Resumo: | Malaria is a parasitic disease caused by unicellular protozoa of the genus Plasmodium and
occurs in more than 90 countries, with the African and Asian continents predominating. The
use of antimalarial drugs is critical for both treatment and prevention of the disease. However,
the parasites began to develop resistance to antimalarials, making it more difficult to control
the parasite. New therapeutic approaches are therefore needed to overcome the parasites' drug
resistance and increase the effectiveness of drug therapy against the disease. The aim of this
research is to characterize the relationships that affect the behavior of protein-ligand
complexes of enzymes from Plasmodium falciparum. The first study aims to characterize
dihydroorotate dehydrogenase (DHODH) and to present the energy levels of the enzyme in
the complexes with wild-type PfDHODH, with ligands DSM483, DSM557, and DSM1, and
with PfDHODH with the C276F mutation together with DMS1. In the second study, tyrosine
RNAt synthetase (TyrRS) is examined, both in its wild-type PfTyrRS linked to ML901-Tyr and
AMS-Tyr, and with the S234C mutation, again in complex with ML901-Tyr. Using the
method of molecular fractionation with conjugated layers (MFCC), amino acid residues were
partitioned to calculate individual interactions using the formalism DFT (Functional Density
Theory). The study with PfDHODH enzyme revealed that amino acid residues Arg265,
Cys184 and Phe188 were crucial for the interactions and exhibited significant interaction
energies with the four complexes studied. Moreover, the energy value of the DSM1 inhibitor
was not affected by the structural changes caused by the C276F mutation, demonstrating its
ability to bind to the enzyme. Working with PfTyrRS, six important residues were found to be
common to the three complexes. These residues include Asp61, Gln73, Gln192, Gln210,
Met237, and Phe63, most of which play essential roles in ATP binding. This discovery
provides a comprehensive understanding of the interaction between PfDHODH and PfTyrRS
enzymes and their inhibitors. The information gathered in this study is proving to be relevant
to the development of new drug therapies and could become a tool in exploring the design of
new, more sophisticated and effective antimalarial drugs. |
---|